Sign Up Today and Learn More About Siolta Therapeutics Stock
Invest in or calculate the value of your shares in Siolta Therapeutics or other pre-IPO companies through EquityZen's platform.
Siolta Therapeutics Stock (SIOT)
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
About Siolta Therapeutics Stock
Founded
2016
Headquarters
San Carlos, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Siolta Therapeutics Press Mentions
Stay in the know about the latest news on Siolta Therapeutics
Kimberly Stopak on Pharmaceutical Industry
jdsupra • Aug 02, 2024
Venture Capital, Labeling, Life Sciences
jdsupra • Aug 02, 2024
Matthew Meyer on Popular
jdsupra • Jun 24, 2024
Siolta Therapeutics: $12 Million Raised To Develop Defined-Consortia Live Biotherapeutic Products
pulse2 • Apr 09, 2024
Siolta Therapeutics Raises $12M in Series C Funding
finsmes • Apr 09, 2024
Siolta Therapeutics Management
Leadership team at Siolta Therapeutics
Board Member
Eric de la Fortelle
Board Observer
Eric de la Fortelle
Join now and verify your accreditation status to gain access to:
- Siolta Therapeutics current valuation
- Siolta Therapeutics stock price
- Available deals in Siolta Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Siolta Therapeutics Stock
How to invest in Siolta Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Siolta Therapeutics through EquityZen funds. These investments are made available by existing Siolta Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Siolta Therapeutics stock?
Shareholders can sell their Siolta Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
